Rezultati pretrage - Sheets, Rebecca
- Prikaz rezultata 1 – 14 od 14
-
1
-
2
-
3
WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20–22 April 20... od Liu, Margaret A., Zhou, Tiequn, Sheets, Rebecca L., Meyer, Heidi, Knezevic, Ivana
Izdano 2022Tekst -
4
Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products od Marcus-Sekura, Carol, Richardson, James C., Harston, Rebecca K., Sane, Nandini, Sheets, Rebecca L.
Izdano 2011Tekst -
5
Toxicological Safety Evaluation of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar Despite Differing Plasmid Backbones o... od Sheets, Rebecca L., Stein, Judith, Manetz, T. Scott, Andrews, Charla, Bailer, Robert, Rathmann, John, Gomez, Phillip L.
Izdano 2006Tekst -
6
Now That You Want to Take Your HIV/AIDS Vaccine/Biological Product Research Concept into the Clinic: What are “cGMP”? od Sheets, Rebecca L., Rangavajhula, Vijaya, Pullen, Jeffrey K., Butler, Chris, Mehra, Vijay, Shapiro, Stuart, Pensiero, Michael
Izdano 2015Tekst -
7
-
8
Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backb... od Sheets, Rebecca L., Stein, Judith, Manetz, T. Scott, Duffy, Chris, Nason, Martha, Andrews, Charla, Kong, Wing-Pui, Nabel, Gary J., Gomez, Phillip L.
Izdano 2006Tekst -
9
Biodistribution and Toxicological Safety of Adenovirus Type 5 and Type 35 Vectored Vaccines Against Human Immunodeficiency Virus-1 (HIV-1), Ebola, or Marburg Are Similar Despite Di... od Sheets, Rebecca L., Stein, Judith, Bailer, Robert T., Koup, Richard A., Andrews, Charla, Nason, Martha, He, Bin, Koo, Edward, Trotter, Holly, Duffy, Chris, Manetz, T. Scott, Gomez, Phillip
Izdano 2008Tekst -
10
Adventitious Agents and Live Viral Vectored Vaccines: Considerations for Archiving Samples of Biological Materials for Retrospective Analysis od Klug, Bettina, Robertson, James S., Condit, Richard C., Seligman, Stephen J., Laderoute, Marian P., Sheets, Rebecca, Williamson, Anna-Lise, Chapman, Louisa, Carbery, Baevin, Mac, Lisa M., Chen, Robert T.
Izdano 2016Tekst -
11
Systematic Evaluation of In Vitro and In Vivo Adventitious Virus Assays for the Detection of Viral Contamination of Cell Banks and Biological Products() od Gombold, James, Karakasidis, Stephen, Niksa, Paula, Podczasy, John, Neumann, Kitti, Richardson, James, Sane, Nandini, Johnson-Leva, Renita, Randolph, Valerie, Sadoff, Jerald, Minor, Phillip, Schmidt, Alexander, Duncan, Paul, Sheets, Rebecca L.
Izdano 2014Tekst -
12
The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)() od Chen, Robert T, Carbery, Baevin, Mac, Lisa, Chapman, Louisa, Condit, Richard C., Excler, Jean-Louis, Gurwith, Marc, Hendry, Michael, Khan, Arifa S., Khuri-Bulos, Najwa, Klug, Bettina, Robertson, Jim S, Seligman, Stephen J., Sheets, Rebecca, Williamson, Anna-Lise
Izdano 2014Tekst -
13
Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains od Condit, Richard C., Williamson, Anna-Lise, Sheets, Rebecca, Seligman, Stephen J., Monath, Thomas P., Excler, Jean-Louis, Gurwith, Marc, Bok, Karin, Robertson, James S., Kim, Denny, Michael Hendry, R., Singh, Vidisha, Mac, Lisa M., Chen, Robert T.
Izdano 2016Tekst -
14
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090) od Fuchs, Jonathan D., Frank, Ian, Elizaga, Marnie L., Allen, Mary, Frahm, Nicole, Kochar, Nidhi, Li, Sue, Edupuganti, Srilatha, Kalams, Spyros A., Tomaras, Georgia D., Sheets, Rebecca, Pensiero, Michael, Tremblay, Marc A., Higgins, Terry J., Latham, Theresa, Egan, Michael A., Clarke, David K., Eldridge, John H.
Izdano 2015Tekst